We are advancing nanomedicine by developing new methods and infrastructure for more rapid prototyping and commercialization of nanobiomedical products, such as new types of sensors. Our long term strategy aims to improve patient care by commercializing nanotechnology and biomedicine more efficiently. Commercializing nanobiotechnology for medical applications is a challenge. Accelerating nanomedical development requires new methods and infrastructure. Now is the time, and we are the right team. The race is on to realize the promise of biomedical nanotechnology.